Jung Shin Lee

2.2k total citations
86 papers, 1.8k citations indexed

About

Jung Shin Lee is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jung Shin Lee has authored 86 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 28 papers in Molecular Biology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jung Shin Lee's work include Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (11 papers) and Gastric Cancer Management and Outcomes (10 papers). Jung Shin Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (11 papers) and Gastric Cancer Management and Outcomes (10 papers). Jung Shin Lee collaborates with scholars based in South Korea, Taiwan and Japan. Jung Shin Lee's co-authors include Eun Kyung Choi, Si Yeol Song, Jae‐Lyun Lee, Tae Won Kim, Seong‐Yun Jeong, Jong Hoon Kim, Yoon‐Koo Kang, Min‐Hee Ryu, Eun Jin Ju and Heung Moon Chang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Jung Shin Lee

85 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jung Shin Lee South Korea	23	590	554	533	276	210	86	1.8k
George H. Hinkle United States	27	432 0.7×	612 1.1×	594 1.1×	271 1.0×	186 0.9×	98	2.4k
Kalevi Kairemo Finland	27	644 1.1×	793 1.4×	799 1.5×	155 0.6×	229 1.1×	164	2.6k
Steve Y. Cho United States	27	645 1.1×	756 1.4×	1.6k 3.1×	423 1.5×	264 1.3×	89	3.5k
J.S.W. Stewart United Kingdom	20	655 1.1×	581 1.0×	435 0.8×	535 1.9×	155 0.7×	36	2.1k
Olga Lyass Israel	14	427 0.7×	669 1.2×	463 0.9×	380 1.4×	100 0.5×	18	1.8k
James Paget United Kingdom	10	587 1.0×	791 1.4×	399 0.7×	518 1.9×	397 1.9×	21	1.9k
Gerben M. Franssen Netherlands	29	542 0.9×	741 1.3×	645 1.2×	277 1.0×	175 0.8×	81	2.3k
Z. Vujaskovic United States	19	335 0.6×	215 0.4×	386 0.7×	400 1.4×	196 0.9×	66	1.4k
J.C. Grecula United States	31	430 0.7×	978 1.8×	1.0k 1.9×	161 0.6×	159 0.8×	159	2.8k
Marco Chinol Italy	32	354 0.6×	1.5k 2.7×	383 0.7×	104 0.4×	164 0.8×	95	3.5k

Countries citing papers authored by Jung Shin Lee

Since Specialization

Citations

This map shows the geographic impact of Jung Shin Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung Shin Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung Shin Lee more than expected).

Fields of papers citing papers by Jung Shin Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung Shin Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung Shin Lee. The network helps show where Jung Shin Lee may publish in the future.

Co-authorship network of co-authors of Jung Shin Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jung Shin Lee. A scholar is included among the top collaborators of Jung Shin Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung Shin Lee. Jung Shin Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Kyoung Jin, Jae Hee Lee, Eun Jin Ju, et al.. (2017). A strategy for actualization of active targeting nanomedicine practically functioning in a living body. Biomaterials. 141. 136–148. 9 indexed citations

Jo, Jae‐Cheol, Ha‐Reum Lee, Dae‐Hee Lee, et al.. (2015). Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity. Molecular Cancer Therapeutics. 14(11). 2613–2622. 22 indexed citations

Choi, Yoon Ji, Dae Ho Lee, Chang‐Min Choi, et al.. (2015). Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR. BMC Cancer. 15(1). 763–763. 15 indexed citations

Hong, Seung-Woo, Jai-Hee Moon, Jooyoung Lee, et al.. (2014). NVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotype. APOPTOSIS. 19(5). 895–904. 26 indexed citations

Jung, Joohee, Seong‐Yun Jeong, Seok Soon Park, et al.. (2014). A cisplatin-incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity. International Journal of Oncology. 46(3). 1268–1274. 13 indexed citations

Park, Seok Soon, Eun Jin Ju, Jinhyang Choi, et al.. (2014). Ibulocydine sensitizes human cancers to radiotherapy by induction of mitochondria-mediated apoptosis. Radiotherapy and Oncology. 112(2). 295–301. 11 indexed citations

Kim, Kyu-pyo, Jin Hee Ahn, Sung‐Bae Kim, et al.. (2012). Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy. Cancer Chemotherapy and Pharmacology. 69(5). 1221–1227. 35 indexed citations

Hong, Seungwoo, Dong‐Hoon Jin, Young-Soon Na, et al.. (2012). Ring Finger Protein 149 Is an E3 Ubiquitin Ligase Active on Wild-type v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF). Journal of Biological Chemistry. 287(28). 24017–24025. 45 indexed citations

Song, Si Yeol, Seong‐Yun Jeong, Heon Joo Park, et al.. (2009). Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer. Lung Cancer. 68(2). 278–282. 12 indexed citations

10.

Jeong, Seong‐Yun, Sung Jin Park, Sang Min Yoon, et al.. (2009). Systemic delivery and preclinical evaluation of Au nanoparticle containing β-lapachone for radiosensitization. Journal of Controlled Release. 139(3). 239–245. 62 indexed citations

11.

Song, Si Yeol, Wonsik Choi, Seong Soo Shin, et al.. (2009). Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung Cancer. 66(1). 89–93. 147 indexed citations

12.

Kim, Tae Won, Min‐Hee Ryu, Sun Jin Sym, et al.. (2009). Kinase Mutations and Efficacy of Imatinib in Korean Patients with Advanced Gastrointestinal Stromal Tumors. The Oncologist. 14(5). 540–547. 15 indexed citations

13.

Kang, Byung Woog, Tae Won Kim, Jae‐Lyun Lee, et al.. (2008). Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis. Medical Oncology. 26(1). 32–37. 47 indexed citations

14.

Kim, Young Seok, Eun Kyung Choi, Jung Shin Lee, et al.. (2007). PD4-1-7: Consolidation chemotherapy with monthly Paclitaxel and Cisplatin (PC) or observation after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer (NSCLS): Randomized phase II study. Journal of Thoracic Oncology. 2(8). S449–S450. 7 indexed citations

15.

Kim, Young Seok, Sang Min Yoon, Eun Kyung Choi, et al.. (2005). Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non–small-cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 62(1). 76–81. 31 indexed citations

16.

Suh, Cheolwon, Sanghee Kim, Hyo Jung Kim, et al.. (2005). Prognostic Factors in Non-Hodgkin's Lymphoma Patients Treated by Autologous Stem Cell Transplantation: A Single Center Experience. Cancer Research and Treatment. 37(5). 294–294. 3 indexed citations

17.

Lee, Sang-wook, Eun Kyung Choi, Jung Shin Lee, et al.. (2003). Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non–small-cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 56(4). 996–1004. 19 indexed citations

18.

Kim, Seong Ho, Cheol Won Suh, Seong Jun Choi, et al.. (1999). Myelodysplastic syndrome that progressed to acute myelomonocytic leukemia with eosinophilia showing peculiar chromosomal abnormality: a case report. Journal of Korean Medical Science. 14(4). 448–448. 2 indexed citations

19.

Lee, Cheol Whan, Cheol Won Suh, Jung Shin Lee, et al.. (1994). Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis. Journal of Korean Medical Science. 9(5). 369–369. 6 indexed citations

20.

Lee, Kyoo Hyung, Jung Shin Lee, Cheolwon Suh, et al.. (1993). Dna flow cytometry of stomach cancer. Prospective correlation with clinicopathologic findings. Cancer. 72(6). 1819–1826. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact